MedPath

Efficacy of fractional CO2 vaginal laser treatment of overactive bladder in Postmenopausal women : a double- blinded randomized controlled study

Phase 4
Conditions
postmenopausal women with overactive bladder symptom
postmenopausal women , overactive bladder , fractional CO2 vaginal laser
Registration Number
TCTR20211022005
Lead Sponsor
Routine to research unit Siriraj Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Enrolling by invitation
Sex
Female
Target Recruitment
50
Inclusion Criteria

postmenopausal women with overactive bladder symptom which in woman complained at least 3 months, frequency of micturition on average at least 8 times per 24 hours and at least three episodes of urgency (at least grade 2 by Patient Perception of Intensity of Urgency Scale )

Exclusion Criteria

Receive hormone therapy within 6 months
Use a moisturizing agent or vaginal lubricant within 30 days.
Received drugs to treat overactive bladder (Antimuscarinics or beta 3 adrenoceptor agonists) within 3 months.
Botox injections treatment around the bladder over a period of 6 months.
Patient having pelvic organ prolapse at level 3 or higher
Patients who have contraindications to the use of vaginal carbon dioxide laser therapy.
Patients who have brain problems and are able to make decisions for oneself.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
overactive bladder symptoms at 2 weeks after end of the intervention ICIQ OAB Thai version
Secondary Outcome Measures
NameTimeMethod
quality of life at 2 weeks after end of the intervention ICIQ OAB Thai version ,side effects of fractional CO2 vaginal laser at 2 weeks after end of the intervention Patient reported outcome using a questionnaire interview
© Copyright 2025. All Rights Reserved by MedPath